BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23175191)

  • 1. The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention.
    Dankner R; Bergman M; Danoff A; Qureshi S; Whitford I; Kaviani N; Dynkevich Y; Roth J
    Diabetes Metab Res Rev; 2013 Jan; 29(1):1-7. PubMed ID: 23175191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
    Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
    J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
    Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
    Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).
    Liberopoulos EN; Florentin M; Kei A; Mountzouri E; Agouridis A; Elisaf MS
    J Clin Hypertens (Greenwich); 2010 Jul; 12(7):543-8. PubMed ID: 20629819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
    Bernal-Lopez MR; Santamaría-Fernandez S; Lopez-Carmona D; Tinahones FJ; Mancera-Romero J; Peña-Jimenez D; Jansen-Chaparro S; Baca-Osorio AJ; Cuesta-Muñoz AL; Serrano-Rios M; Gomez-Huelgas R
    Diabet Med; 2011 Nov; 28(11):1319-22. PubMed ID: 21966956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in an acute-care setting.
    Silverman RA; Thakker U; Ellman T; Wong I; Smith K; Ito K; Graff K
    Diabetes Care; 2011 Sep; 34(9):1908-12. PubMed ID: 21775751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HbA(1c) measurement for the diagnosis of diabetes: is it enough?
    Cavagnolli G; Comerlato J; Comerlato C; Renz PB; Gross JL; Camargo JL
    Diabet Med; 2011 Jan; 28(1):31-5. PubMed ID: 21210540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
    Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
    Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
    Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
    Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
    Borg R; Vistisen D; Witte DR; Borch-Johnsen K
    Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoglobin A1c is not a surrogate for glucose and insulin measures for investigating the early life and childhood determinants of insulin resistance and Type 2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and Children (ALSPAC).
    Shultis WA; Leary SD; Ness AR; Scott J; Martin RM; Whincup PH; Smith GD;
    Diabet Med; 2006 Dec; 23(12):1357-63. PubMed ID: 17116188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?
    Cosson E; Nguyen MT; Hamo-Tchatchouang E; Banu I; Chiheb S; Charnaux N; Valensi P
    Diabet Med; 2011 May; 28(5):567-74. PubMed ID: 21480967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting from glucose diagnostic criteria to the new HbA(1c) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population.
    Costa B; Barrio F; Cabré JJ; Piñol JL; Cos FX; Solé C; Bolibar B; Castell C; Lindström J; Barengo N; Tuomilehto J;
    Diabet Med; 2011 Oct; 28(10):1234-7. PubMed ID: 21429007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus.
    Tekumit H; Cenal AR; Polat A; Uzun K; Tataroglu C; Akinci E
    Ann Thorac Surg; 2010 May; 89(5):1482-7. PubMed ID: 20417764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
    Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
    Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study.
    Pajunen P; Peltonen M; Eriksson JG; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J; Lindström J;
    Diabet Med; 2011 Jan; 28(1):36-42. PubMed ID: 21166843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with high glycated hemoglobin levels (≥5.7%) in Korean adults with normal fasting glucose.
    Choi SY; Yun KE; Choi HJ
    J Endocrinol Invest; 2012 Sep; 35(8):730-4. PubMed ID: 21970859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.